4-Hydroxy-N-propylbenzamide, 98%, 5g

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one, 95.0%, 1g

3-Bromo-2-hydroxyphenyl boronic acid, 97%, 1g

(2E)-1-(4-fluorophenyl)-3-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

1,3-butandiolo, minimo 99%, per sintesi, 25 l, confezione in plastica.

6-Bromo-8-methylimidazo[1,2-a]pyridin-2-amine, 97.0%, 5g

2-[2-(4-methyl-1,3-thiazol-5-yl)-1h-1,3-benzodiazol-1-yl]acetic acid, 95%, 1g

tert-Butyl acrylate (stabilised with MEHQ), 98.0%, 500ml

3,5-Dibromo-4-methoxybenzaldehyde, 95.0%, 5g

7-Methoxy-1H-indazole, 95.0%, 10g

cyclobutyl 2,5-dichlorophenyl ketone, 97.0%, 1g

Ethyl 1H-pyrrole-3-carboxylate, 95.0%, 5g

1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea, 50mg